@.hormonepositivej: 🎗️ WHAT IS TRIPLE-POSITIVE BREAST CANCER? You’ve probably heard of triple-negative breast cancer, but did you know breast cancer can also be called triple-positive? Triple-positive generally means the cancer is: ✅ ER-positive — estrogen receptor positive ✅ PR-positive — progesterone receptor positive ✅ HER2-positive — HER2 overexpression or amplification So what does that actually mean? 🧬 THREE IMPORTANT TARGETS Think of cancer biomarkers like clues telling doctors what is helping the cancer grow—and what they may be able to target. ER+ and PR+ mean the cancer cells have hormone receptors. Estrogen signaling—and sometimes progesterone-receptor biology—helps characterize the tumor as hormone-receptor positive. HER2+ means the cancer has too much HER2 protein and/or extra copies of the HER2 gene, which can send strong growth signals to the cancer cells. So triple-positive breast cancer has features of both hormone-receptor-positive AND HER2-positive disease. 💊 WHY DOES THAT MATTER? Because having these biomarkers also gives doctors multiple treatment targets. Treatment may include a combination of: 💉 Chemotherapy 🎯 HER2-targeted therapy, such as trastuzumab (Herceptin), and in some situations pertuzumab (Perjeta) or other HER2-directed medications. 🌸 Hormone/endocrine therapy, such as tamoxifen or an aromatase inhibitor, because the cancer is hormone-receptor positive. 🏥 Surgery ☢️ Radiation, when indicated. The exact combination depends on the cancer’s stage, tumor size, lymph nodes, response to treatment and individual health. 🎯 IS TRIPLE-POSITIVE MORE AGGRESSIVE? HER2-positive cancers historically tended to grow and spread more aggressively than many HER2-negative cancers. But treatment has changed dramatically. HER2-positive breast cancer now has some of the most effective targeted therapies available in breast cancer treatment. So hearing HER2-positive does NOT automatically mean a poor outcome. ❤️ IS TRIPLE-POSITIVE THE “GOOD” OR “BAD” KIND? Neither. There’s no “good cancer.” But triple-positive breast cancer has something very important: Multiple biological targets doctors can treat. Doctors can attack the HER2 pathway AND reduce hormone-driven signaling. That’s why knowing your receptors matters so much. 🎗️ REMEMBER IT THIS WAY: ER+ → estrogen receptor is present PR+ → progesterone receptor is present HER2+ → HER2 is overexpressed/amplified TRIPLE-POSITIVE = ALL THREE ARE POSITIVE. Your breast cancer diagnosis isn’t only about where the cancer is. It’s also about what is driving the cancer and what treatments can target it. 👇 BREAST CANCER FAMILY: Were you diagnosed ER/PR+, HER2+, triple-positive, or triple-negative? 📚 SOURCES: • National Cancer Institute — Breast Cancer Biomarker Tests • National Cancer Institute — HER2-Positive Breast Cancer • National Cancer Institute — Hormone Therapy for Breast Cancer • American Cancer Society — Breast Cancer Hormone Receptor Status • American Cancer Society — HER2-Positive Breast Cancer #breastcancer #cancer #fyp #womenshealth #cancersurvivor ⚠️ Educational only. “Triple-positive” is an informal description rather than a separate official breast-cancer subtype. Treatment is individualized based on the complete pathology, stage and other clinical factors.

@HormonePositiveJourney

Open In TikTok:

Region: US

Sunday 13 September 2026 21:22:59 GMT